The chemical structure of some marketed AMPs. For gramicidin D and teicoplanin, only probably the most abundant parts in the clinically used mixtures are revealed. In this way, peptide-based drug development could be important for your future of focused treatment method.4 Peptides, with their vast therapeutic likely and inherent specificity,